A Safety Study of Infusion of Ex Vivo Selectively Amplified Unrelated Cord Blood Stem Cells in Subjects With Hematological Malignancies Receiving Unrelated Cord Blood Transplantation
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Kurt Gunter, MD
Study Director
ViaCell
United States: Food and Drug Administration
CB001
NCT00089596
March 2004
October 2006
Name | Location |
---|---|
Roswell Park Cancer Institute | Buffalo, New York 14263 |
Indiana University Cancer Center | Indianapolis, Indiana 46202-5265 |
Loyola University Medical Center | Maywood, Illinois 60153 |
Hackensack University Medical Center | Hackensack, New Jersey 07601 |